Demographic and Viral-Genetic Analyses of COVID-19 Severity in Bahrain Identify Local Risk Factors and a Protective Effect of Polymerase Mutations.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
12 Oct 2023
Historique:
pubmed: 30 8 2022
medline: 30 8 2022
entrez: 29 8 2022
Statut: epublish

Résumé

A multitude of demographic, health, and genetic factors are associated with the risk of developing severe COVID-19 following infection by the SARS-CoV-2. There is a need to perform studies across human societies and to investigate the full spectrum of genetic variation of the virus. Using data from 869 COVID-19 patients in Bahrain between March 2020 and March 2021, we analyzed paired viral sequencing and non-genetic host data to understand host and viral determinants of severe COVID-19. We estimated the effects of demographic variables specific to the Bahrain population and found that the impact of health factors are largely consistent with other populations. To extend beyond the common variants of concern in the Spike protein analyzed by previous studies, we used a viral burden approach and detected a protective effect of low-frequency missense viral mutations in the RNA-dependent RNA polymerase (Pol) gene on disease severity. Our results contribute to the survey of severe COVID-19 in diverse populations and highlight the benefits of studying rare viral mutations.

Identifiants

pubmed: 36032980
doi: 10.1101/2022.08.13.22278740
pmc: PMC9413726
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL150284
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM127131
Pays : United States

Auteurs

Evan M Koch (EM)

Department of Biomedical Informatics, Harvard Medical School.

Justin Du (J)

Yale University.

Michelle Dressner (M)

Harvard T.H. Chan School of Public Health.

Hashmeya Erahim Alwasti (HE)

Public Health Laboratories, Public Health Directorate, Bahrain Ministry of Health.

Zahra Al Taif (Z)

Public Health Laboratories, Public Health Directorate, Bahrain Ministry of Health.

Fatima Shehab (F)

Public Health Laboratories, Public Health Directorate, Bahrain Ministry of Health.

Afaf Merza Mohamed (AM)

Public Health Laboratories, Public Health Directorate, Bahrain Ministry of Health.

Amjad Ghanem (A)

Public Health Laboratories, Public Health Directorate, Bahrain Ministry of Health.

Amani Alhajeri (A)

Genetic Department, Government Hospitals, Salmaniya Medical Complex, Manama, Kingdom of Bahrain.

Amna Alawadhi (A)

Genetic Department, Government Hospitals, Salmaniya Medical Complex, Manama, Kingdom of Bahrain.

Nabeel Almoamen (N)

Genetic Department, Government Hospitals, Salmaniya Medical Complex, Manama, Kingdom of Bahrain.

Khulood Ashoor (K)

Genetic Department, Government Hospitals, Salmaniya Medical Complex, Manama, Kingdom of Bahrain.

Sara Hasan (S)

Genetic Department, Government Hospitals, Salmaniya Medical Complex, Manama, Kingdom of Bahrain.

Alireza Haghighi (A)

Division of Genetics, Department of Medicine, Brigham and Women's Hospital.
Department of Genetics, Harvard Medical School.
Broad Institute of MIT and Harvard.

Shamil Sunyaev (S)

Department of Biomedical Informatics, Harvard Medical School.
Division of Genetics, Department of Medicine, Brigham and Women's Hospital.

Maha Farhat (M)

Department of Biomedical Informatics, Harvard Medical School.
Pulmonary and Critical Care Medicine, Massachusetts General Hospital.

Classifications MeSH